News

Merck backs microbial Dx outfit as concern about treatment-resistant strains grows

Diagnostics company AdvanDx is getting a $12 million infusion from the Merck Global Health Innovation Fund to expand its product offerings and sales and marketing efforts in the U.S. and abroad.

InfoBionic brings in $17M to develop its cloud-based patient monitoring system

InfoBionic raised $17 million in Series B financing to develop its innovative patient monitoring system for cardiac arrhythmia.

Adaptive Biotechnologies raises $120M to bolster its immune Dx

Seattle-based Adaptive Biotechnologies announced April 7 that it has completed two rounds of financing, netting the company $120 million that it will use to expand sales of existing products and develop new ones. 

Study: Medtronic's tech helped paraplegics move again

A combination of physical therapy and treatment with Medtronic's spinal-cord-stimulating devices helped three men with paraplegia move their extremities and briefly stand up on their own, The Wall Street Journal reports, regaining voluntary movement years after their injuries.

Sequent bags $20M to get its aneurysm tech on the U.S. market

California's Sequent Medical has raked in $20 million in venture cash to support its device to treat brain aneurysms, a CE marked technology on the verge of U.S. clinical trials.

Deerfield unveils a $1.6B new fund as med tech VC lags

The financial backer of Trivascular Technologies, Mako Surgical, Foundation Medicine and other prominent players announced that it is committing an additional $1.6 billion to a new fund for healthcare companies.

JenaValve pockets another $10M as it vies with Medtronic, Edwards

JenaValve, the venture-backed upstart in the top-heavy aortic valve space, has bagged a $10 million extension to its Series C funding round, cash that'll help it contend with the likes of Edwards Lifesciences and Medtronic on the European market.

Daktari Diagnostics brings in $13M to fund its HIV test

Daktari Diagnostics achieved another milestone in its quest to raise $30 million for its groundbreaking HIV test. The company recently brought in $13 million in equity, moving it closer to realizing its original fundraising goal, the Boston Business Journal reports.

Merck KGaA signs on to sell Auxogyn's IVF test

Germany's Merck KGaA signed a licensing agreement with Menlo Park, CA-based Auxogyn to sell its fertility-enhancing diagnostic test in Europe and Canada with an option to extend the agreement to other countries.

Exact Sciences raises $120M to get its cancer test on the market

A week after swaying an FDA panel with its colorectal cancer test, Exact Sciences raised $119.7 million through a stock offering, flipping 10 million shares at $12.75 each.

Medtronic buys out a distributor as it cozies up to Turkey

Medtronic is looking to bypass some middlemen in its Turkish operation, buying a controlling stake in one of its distributors and launching a joint venture as it works to expand its share of the growing medical device market.

Roche snags diagnostics outfit IQuum in $450M deal

Roche is beefing up its point-of-care molecular diagnostics offerings, signing a deal to acquire Marlborough, MA-based IQuum for $275 million up front and up to $175 million in milestone-based payments.

Edwards Lifesciences wins CE mark for aortic valve system

Edwards Lifesciences won a CE mark for its innovative aortic valve system. European approval for the device comes at a critical moment for the company, as it attempts to strengthen its hold on foreign markets and stay a step ahead of its competition.

CyVek immunoassay technology gets $10M investment

CyVec and its immunoassay technology got a $10 million investment shot in the arm from Minneapolis-based Bio-Techne with an additional promise to acquire the company in the future if certain conditions are met.

TriVascular Technologies to target $13-$15 per share as IPO terms become clear

TriVascular Techologies is setting the terms for its planned IPO, and the California maker of stent grafts to treat abdominal aortic aneurysms aims for a fairly robust debut.

Jury partially faults J&J in another vaginal mesh trial verdict

Johnson & Johnson's Ethicon arm has been ordered to pay $1.2 million in damages in a trial alleging it produced faulty vaginal mesh that was implanted into a 64-year-old woman.

Holaira brings in $42M Series D to test COPD lung denervation treatment tool

Minnesota startup Holaira attracted $42 million in new financing that will back a formal human clinical trial for a lung denervation treatment that addresses chronic obstructive pulmonary disease.

RefleXion raises $11.6M in Series A funding round

RefleXion Medical raised $11.6 million in a Series A financing round for its biologically guided radiation system for cancer treatment.

 

Vapotherm seals $24M financing round, elects new board member

Vapotherm, a maker of respiratory therapy devices, disclosed this week it finalized a $24 million round of funding from a consortium of 8 investors and expanded its board.

The U.K.'s Cytox attracts $2.5M in new investment to pursue Alzheimer's biomarker work

U.K. diagnostics developer Cytox raised nearly $2.5 million in new funding to help expand work on the development of a viable Alzheimer's biomarker.